Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889.

MLA

Endo, Mika, et al. “Augmentation of the Antitumor Activity of Capecitabine by a Tumor Selective Dihydropyrimidine Dehydrogenase Inhibitor, RO0094889.” International Journal of Cancer, vol. 106, no. 5, Sept. 2003, pp. 799–805. EBSCOhost, https://doi.org/10.1002/ijc.11276.

APA

Endo, M., Miwa, M., Eda, H., Ura, M., Tanimura, H., Ishikawa, T., Miyazaki-Nose, T., Hattori, K., Shimma, N., Yamada-Okabe, H., & Ishitsuka, H. (2003). Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889. International Journal of Cancer, 106(5), 799–805. https://doi.org/10.1002/ijc.11276

Chicago

Endo, Mika, Masanori Miwa, Hiroyuki Eda, Masako Ura, Hiromi Tanimura, Tohru Ishikawa, Taeko Miyazaki-Nose, et al. 2003. “Augmentation of the Antitumor Activity of Capecitabine by a Tumor Selective Dihydropyrimidine Dehydrogenase Inhibitor, RO0094889.” International Journal of Cancer 106 (5): 799–805. doi:10.1002/ijc.11276.